[HTML][HTML] Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance

Y Zhu, T Xia, DQ Chen, X Xiong, L Shi, Y Zuo… - Drug Resistance …, 2023 - Elsevier
Drug resistance remains a major challenge in cancer treatment, necessitating the
development of novel strategies to overcome it. Protein arginine methyltransferases …

Role of intracellular iron in switching apoptosis to ferroptosis to target therapy-resistant cancer stem cells

SL Pandrangi, P Chittineedi, SS Chalumuri, AS Meena… - Molecules, 2022 - mdpi.com
Iron is a crucial element required for the proper functioning of the body. For instance,
hemoglobin is the vital component in the blood that delivers oxygen to various parts of the …

Co-culture of tumor spheroids and fibroblasts in a collagen matrix-incorporated microfluidic chip mimics reciprocal activation in solid tumor microenvironment

SY Jeong, JH Lee, Y Shin, S Chung, HJ Kuh - PloS one, 2016 - journals.plos.org
Multicellular 3D culture and interaction with stromal components are considered essential
elements in establishing a 'more clinically relevant'tumor model. Matrix-embedded 3D …

The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms

YX Jiang, SW Yang, PA Li, X Luo, ZY Li, YX Hao… - Oncogene, 2017 - nature.com
Postoperative recurrence and metastasis have crucial roles in the poor prognosis of gastric
cancer patients. Previous studies have indicated that gastric cancer originates from cancer …

Integrating molecular networking and biological assays to target the isolation of a cytotoxic cyclic octapeptide, samoamide A, from an American Samoan marine …

CB Naman, R Rattan, SE Nikoulina, J Lee… - Journal of natural …, 2017 - ACS Publications
Integrating LC-MS/MS molecular networking and bioassay-guided fractionation enabled the
targeted isolation of a new and bioactive cyclic octapeptide, samoamide A (1), from a …

CD26/DPP-4: type 2 diabetes drug target with potential influence on cancer biology

E Kawakita, D Koya, K Kanasaki - Cancers, 2021 - mdpi.com
Simple Summary Dipeptidyl peptidase (DPP)-4 inhibitor is widely used for type 2 diabetes.
Although DPP-4/CD26 has been recognized as both a suppressor and inducer in tumor …

Cancer stem cells and epithelial–mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches

D Fang, H Kitamura - International Journal of Urology, 2018 - Wiley Online Library
There is growing evidence of the presence of cancer stem cells in urothelial carcinoma.
Cancer stem cells have the ability to self‐renew and to differentiate into all cell types of the …

Mechanisms of tumor cell resistance to the current targeted-therapy agents

G Khamisipour, F Jadidi-Niaragh, AS Jahromi, K Zandi… - Tumor Biology, 2016 - Springer
Resistance to chemotherapy agents is a major challenge infront of cancer patient treatment
and researchers. It is known that several factors, such as multidrug resistance proteins and …

Metformin mitigates DPP-4 inhibitor-induced breast cancer metastasis via suppression of mTOR signaling

E Kawakita, F Yang, A Kumagai, Y Takagaki… - Molecular Cancer …, 2021 - AACR
The biological influence of antidiabetic drugs on cancer cells and diabetic cancer patients
has not yet been completely elucidated. We reported that a dipeptidyl peptidase (DPP)-4 …

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers

E Angevin, N Isambert, V Trillet-Lenoir, B You… - British Journal of …, 2017 - nature.com
Background: YS110 is a humanised IgG1 monoclonal antibody with high affinity to the CD26
antigen. YS110 demonstrated preclinical anti-tumour effects without significant side effects …